Skip to main content

Table 2 EGFR expression features in OC patients (420 cases)

From: Near-infrared fluorescent molecular probes with cetuximab in the in vivo fluorescence imaging for epithelial ovarian cancer

Characteristics

N (%)

EGFR expression [N (%)]

χ2

p value

Low (H-score ≤ 96.83)

High (H-score > 96.83)

Age at diagnosis (years)

   

2.089

0.148

  ≤ 50

149 (35.5)

80(53.7)

69(46.3)

  

  > 50

269 (64.0)

164(61.0)

105(39.0)

  

  Unknown

2 (0.5)

    

 Menopause

   

0.954

0.329

  No

150 (35.7)

84(56.0)

66(44.0)

  

  Yes

256 (61.0)

156(60.9)

100(39.1)

  

  Unknown

14 (3.3)

    

Histological subtypes

   

7.106

0.008*

 Serous

371 (88.3)

209 (56.3)

162 (43.7)

  

 Nonserous

44 (10.5)

34 (77.3)

10 ((22.7)

  

  Unknown

5 (1.2)

    

 FIGO stage

   

2.706

0.439

  I

43 (10.2)

22 (51.2)

21 (48.8)

  

  II

34 (8.1)

23 (67.6)

11 (32.4)

  

  III

291 (69.3)

172 (59.1)

119 (40.9)

  

  IV

18 (4.3)

9 (50.0)

9 (50.0)

  

  Unknown

34 (8.1)

    

Histological grade

   

13.344

0.001*

  Grade 1

24 (5.8)

6 (25.0)

18 (75.0)

  

  Grade 2

17 (4.0)

13 (76.5)

4 (23.5)

  

  Grade 3

332 (79.0)

197(59.3)

135 (40.7)

  

  Unknown

47 (11.2)

    

Lymph node metastasis

   

0.106

0.744

  Negtive

136 (32.4)

81(59.6)

55(40.4)

  

  Positive

76 (18.1)

47(61.8)

29(38.2)

  

  Unknown

208 (49.5)

    

 Ascites (mL)

   

1.503

0.220

  < 500

87 (20.7)

46 (52.9)

41(47.1)

  

  ≥ 500

213 (50.7)

129 (60.6)

84(39.4)

  

  Unknown

120 (28.6)

    

Preoperative CA125 (U/ml)

     

  < 35

28 (6.7)

17(60.7)

11(39.3)

0.091

0.763

  ≥ 35

372 (88.5)

215(57.8)

157(42.2)

  

  Unknown

20 (4.8)

    

Residual tumor size (cm)

     

  ≤ 1

137 (32.6)

67(48.9)

70(51.1)

14.266

0.000*

  > 1

59 (14.1)

46(78.0)

13(22.0)

  

  Unknown

224 (53.3)

    

Platinum resistance

     

  No

91 (21.7)

44(48.4)

47(51.6)

0.782

0.377

  Yes

35 (8.3)

20(57.1)

15(42.9)

  

  Unknown

294 (70.0)

    

 Relapse

     

  No

123 (29.3)

50 (40.7)

73 (59.3)

15.991

0.000*

  Yes

141 (33.6)

92 (65.2)

49 (34.8)

  

 Unknown

156 (37.1)

    

 Death

   

9.151

0.002*

  No

182 (43.3)

94(51.6)

88(48.4)

  

  Yes

142 (33.8)

97(68.3)

45(31.7)

  

 Unknown

96 (22.9)

    
  1. *p < 0.05. OC, ovarian cancer; FIGO, International Federation of Gynecology and Obstetrics; CA125, cancer antigen 125